¶ Pfizer-BioNTech COVID-19 vaccine
This page has moved! Click here to view the most up-to-date version of this page on the White Rose Wiki.
The Pfizer-BioNTech COVID-19 vaccine is a term used to describe multiple COVID-19 vaccine candidates and products developed by Pfizer and BioNTech. The term is most commonly refers to BNT162b2, but is increasingly used to refer to subsequent reformulated versions including those for the XBB.1.5 variant of SARS-CoV-2. Its official brand name is Comirnaty.
¶ National contracts
Albania
Between Pfizer, the Albanian Ministry of Health and Social Protection and the Institute of Public Health in Albania.
- January 6, 2021: Manufacturing and Supply Agreement
Brazil
Between Pfizer and the Ministry of Health of Brazil.
- March 18, 2021: Purchase Agreement
Canada
Between Pfizer and the Minister of Public Works and Government Services Canada.
- October 26, 2020: Manufacturing and Supply Agreement
South Africa
Between Pfizer and the National Department of Health of South Africa.
- March 30, 2021: Manufacturing and Supply Agreement
- June 4, 2021: Amendment to Manufacturing and Supply Agreement
- Binding Term Sheet
¶ Product monographs
Canada
- September 28, 2023: COMIRNATY® Omicron XBB.1.5